printable article

Originally published August 17 2006

Jury finds Merck negligent in Vioxx trial, awards $50 million to retired FBI agent

by NaturalNews

(NaturalNews) A New Orleans jury deciding a case brought against Vioxx maker Merck & Co. by a heart attack victim says the pharmaceutical firm should pay the plaintiff $50 million in compensatory damages.

Gerald Barnett, a 62-year-old retired FBI agent, took Vioxx for 31 months before he suffered a heart attack in July 2002. Four years earlier, Barnett had undergone quintuple bypass surgery after a heart attack at the age of 58. Following the heart attack and surgery, Barnett exercised daily, maintained a healthy diet and took prescription drugs to lower his cholesterol.

Barnett stopped taking Vioxx a week before Merck pulled it off the market in September 2004, after studies surfaced revealing that the drug increased the risk of stroke and heart attack. Barnett's attorney, Mark Robinson, says Vioxx caused his client's second heart attack.

After deliberating for less than six hours, the jury returned with a verdict for Barnett, charging that Merck was negligent in failing to adequately warn Barnett's doctors about the risks of the drug, and that the drug firm "knowingly misrepresented or failed to disclose" drug information to Barnett's doctors. The jury chose to assign all blame to Merck, and none to various physicians involved in the case.

Barnett's lawsuit against Merck for problems with Vioxx is among more than 16,000 such suits nationwide. State and federal courts have so far sided with Merck in five cases and the plaintiffs in two.


All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit